PortfoliosLab logoPortfoliosLab logo

Langar Global HealthTech ETF (LGHT) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with LGHT. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.

Cheapest Alternatives to LGHT

LGHT charges 0.85% annually. There are 54 ETFs in the Health & Biotech Equities category with lower expense ratios, going as low as 0.08%.


Best Risk-Adjusted Alternatives to LGHT

LGHT has a PortfoliosLab risk / return rank of 1. There are 54 ETFs in the Health & Biotech Equities category with higher risk-adjusted ranks, going as high as 89.


Top Performing LGHT Alternatives (YTD)

LGHT is at -19.52% YTD. There are 61 ETFs in the Health & Biotech Equities category with higher YTD returns, going as high as 20.15%.


Lowest Volatility Alternatives to LGHT

LGHT has 18.29% 1-year volatility. There are 28 ETFs in the Health & Biotech Equities category with lower 1-year volatility, going as low as 0.00%.


Lowest Drawdown Alternatives to LGHT

LGHT has a 1-year max drawdown of -25.57%. There are 51 ETFs in the Health & Biotech Equities category with shallower 1-year drawdowns, going as shallow as 0.00%.


Often Compared With LGHT

Investors most often compare LGHT with BBH, BNO, DBE. These 15 comparison targets span 4 categories, based on PortfoliosLab usage data.


Compare LGHT with Any Fund or Stock

Compare LGHT with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


 

Diversifiers

Pair LGHT with funds that move differently

Langar Global HealthTech ETF alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to LGHT.

Explore LGHT Diversifiers